Status:
COMPLETED
Electronic Hookah and Endothelial Cell Function
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Tobacco Related Disease Research Program
Conditions:
Smoking
Endothelial Dysfunction
Eligibility:
All Genders
21-39 years
Phase:
NA
Brief Summary
Electronic nicotine delivery systems (ENDS) are a rapidly growing global epidemic among adolescents and young adults. Unlike other ENDS such as e-cigarettes, e-hookahs are used through traditional wat...
Eligibility Criteria
Inclusion
- 21-39 years old hookah smokers: smoked hookah \>12x in last 12 months
- 21-39 years old e-cigarette users: vaped \>12x in last 12 months
- no history of illicit drugs
- no evidence of cardiopulmonary disease by history/ physical
- no diabetes: fasting blood glucose \<100 mg/dl
- BP\<140/90mmHg
- resting HR\<100 bpm
- BMI\<30kg•m2
- no prescription medication
Exclusion
- exhaled CO\>10 ppm (smoking non-abstinence)
- positive pregnancy test
- psychiatric illness
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2023
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04133376
Start Date
November 1 2019
End Date
May 29 2023
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90024